Commentary on "The road to reliable peptide assays is paved with good guidelines"
Clin Endocrinol (Oxf)
.
2023 Jun;98(6):763-765.
doi: 10.1111/cen.14894.
Epub 2023 Mar 13.
Authors
Anna M Kowalka
1
,
Kleopatra Alexiadou
1
,
Joyceline Cuenco
1
,
Rosemary E Clarke
2
,
Stephane Camuzeaux
3
4
,
James Minnion
1
,
Emma L Williams
5
,
Paul Bech
1
,
Sanjay Purkayastha
6
,
Ahmed R Ahmed
6
,
Zoltan Takats
3
4
,
Bernard Khoo
7
,
Harry J Whitwell
3
4
,
Maria G Romero
3
4
,
Stephen R Bloom
1
,
Matthew R Lewis
3
4
,
Tricia M-M Tan
1
Affiliations
1
Section of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
2
Blood Sciences Department, Raigmore Hospital, Inverness, UK.
3
Section of Bioanalytical Chemistry, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
4
National Phenome Centre, Imperial College London, London, UK.
5
Department of Clinical Biochemistry, North West London Pathology, Charing Cross Hospital, London, UK.
6
Department of Surgery and Cancer, Imperial College Healthcare NHS Trust, London, UK.
7
Endocrinology, Division of Medicine, University College London, London, UK.
PMID:
36915993
PMCID:
PMC10952462
DOI:
10.1111/cen.14894
No abstract available
Keywords:
bariatric surgery; mass spectrometry; peptide YY.
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Obesity*
Peptides*
Substances
Peptides
Grants and funding
MR/K02115X/1/MRC_/Medical Research Council/United Kingdom
13/121/07/DH_/Department of Health/United Kingdom